MDM2 and soft tissue sarcoma: Second, The Cancer Genome Atlas analysis of soft tissue sarcomas demonstrated that dedifferentiated liposarcoma, conventionally classified by the presence of MDM2 amplification, formed two methylation groups which corresponded to significantly different clinical outcomes [11].